Drugs / VAC BNO 1095
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01870687 | Jun 2013 → Oct 2014 | breast disorder, premenstrual tension | Bionorica SE | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01309113 Comparator | Mar 2011 → Jan 2012 | breast disorder, premenstrual tension | Bionorica SE | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VAC BNO 1095 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01309113 ↗ |
| Route | Oral | “oral” NCT01870687 ↗ |